References

 
  1. Home
  2. References
 

Home Page

References:

1. Cascale TB, Adrade C, Roger QU. Safety and efficacy of Once-Daily Fexofenadine HCI in the Treatment of Autumn Seasonal Allergic Rhinitis. Allergy and Asthma Proc 1999;20:193-198.

2. Meltzer EO. Evaluation of the Optimal Oral Antihistamine for Patients With Allergic Rhinitis. Mayo Clin Proc 2005;80(9):1170-1176.

3. Banerji A, Long AA, Camargo CA. Diphenhydramine versus non-sedation antihistamines for acute allergic rhinitis: A literature review. Allergy Asthma Proc 2007;28:418-426.

4. Meeves SG, Appajosyula S. Efficacy and safety profile of fexofenadine HCI: A unique therapeutic option in H1-receptor antagonist treatment. J Allergy Clin Immunol 2003;112(4):S69-S77.

5. TELFAST® 120 (tablets) package insert. December 2006.

6. TELFAST® 180 (tablets) package insert. September 1998.

7. American College of Allergy, Asthma & Immunology ACAAI. [online] [cited 2019 Jul 1] Available from URL:
https://acaai.org/allergies/types-allergies/hives-urticaria

8. TELFAST® Suspension package insert. July 2009,

About TELFAST®

References:

1. Cascale TB, Adrade C, Roger QU. Safety and efficacy of Once-Daily Fexofenadine HCI in the Treatment of Autumn Seasonal Allergic Rhinitis. Allergy and Asthma Proc 1999;20:193-198.

2. Meltzer EO. Evaluation of the Optimal Oral Antihistamine for Patients With Allergic Rhinitis. Mayo Clin Proc 2005;80(9):1170-1176.

3. Banerji A, Long AA, Camargo CA. Diphenhydramine versus non-sedation antihistamines for acute allergic rhinitis: A literature review. Allergy Asthma Proc 2007;28:418-426.

4. TELFAST® 120 (tablets) package insert. December 2006.

5. TELFAST® 180 (tablets) package insert. September 1998.

6. TELFAST® Suspension package insert. July 2009,

7. Meeves SG, Appajosyula S. Efficacy and safety profile of fexofenadine HCI: A unique therapeutic option in H1-receptor antagonist treatment. J Allergy Clin Immunol 2003;112(4):S69-S77.

8. American College of Allergy, Asthma & Immunology ACAAI. [online] [cited 2019 Jul 1] Available from URL:
https://acaai.org/allergies/types-allergies/hives-urticaria

Allergy Facts – What is allergy

References:

1. MayoClinic. Allergies. [online] [cited 2019 August 26]. Available from: URL:
https://www.mayoclinic.org/diseases-conditions/allergies/symptoms-causes/syc-20351497?p=1

2. ASCIA. Information for patients, consumer and carers. What is Allergy? [online] [cited on 2019 August 26]. Available from: URL:
https://www.allergy.org.au/patients/about-allergy/what-is-allergy

3. Meltzer EO. Evaluation of the Optimal Oral Antihistamine for Patients with Allergic Rhinitis. Mayo Clin Proc 2005;80(9):1170-1176.

4. Cascale TB, Adrade C, Roger QU. Safety and efficacy of Once-Daily Fexofenadine HCI in the Treatment of Autumn Seasonal Allergic Rhinitis. Allergy and Asthma Proc 1999;20:193-198.

5. American Academy of Allergy Asthma and Immunology AAAAI. Allergy Statistics. [online] [cited on 2019 August 27] Available from :URL:
https://www.aaaai.org/about-aaaai/newsroom/allergy-statistics

6. Allergy foundation South Africa. AFSA. Allergy. [online] [cited on 2019 August 27]. Available from: URL:
https://www.allergyfoundation.co.za/allergy-and-immunology/allergy/

Allergy Facts – Types of allergy

References:

1. ASCIA Society of Clinical Immunology and Allergy. What is allergy? [Online] [cited 2019 June18] Available from: URL:
https://www.allergy.org.au/patients/about-allergy/what-is-allergy

2. ASCIA Society of Clinical Immunology and Allergy. Is it allergic rhinitis? [Online] [cited 2019 June18] Available from: URL: https://www.allergy.org.au/patients/allergic-rhinitis-hay-fever-andsinusitis/ allergic-rhinitis-or-hay-fever

3. Meltzer EO. Evaluation of the Optimal Oral Antihistamine for Patients with Allergic Rhinitis. Mayo Clin Proc 2005;80(9):1170-1176.

4. American College of Allergy, Asthma & Immunology. ACAAI [online] [cited 2019 June 18] Available from: URL:
https://acaai.org/allergies/types/hay-fever-rhinitis

Allergy Facts – What is urticaria (hives)

Reference:

1. American College of Allergy, Asthma & Immunology. ACAAI [online] [cited 2019 June 18] Available from: URL:
https://acaai.org/allergies/types-allergies/hives-urticaria

Allergy Facts – Allergy vs Cold

Reference:

1. American Academy of Allergy Asthma & Immunology AAAI. Pongdee T. Colds, Allergies and Sinusitis. How to tell the Difference. [online] [cited 2019 August 27] Available from URL:
https://www.aaaai.org/Aaaai/media/.../EL-allergies-colds-allergies-sinusitis-patient.pdf

Managing Allergies – Smart steps to prevent allergy

References:

1. MayoClinic. Allergies. [online] [cited 2019 August 27] Available from: URL:
https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351503

2. WebMD. Allergy Medications. [online] [cited 2019 August 27] Available from: URL:
https://www.webmd.com/allergies/allergy-medications?print=true

Managing Allergies – How to prevent allergic rhinitis (hay fever)

References:

1. Mayo Clinic. Allergies. Diagnosis and treatment. [online] [cited 2019 August 27] Available from: URL:
https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351503

2. Mayo Clinic. Allergies, Overview. Symptoms and causes. [online] [cited 2019 August 27] Available from: URL:
https://www.mayoclinic.org/diseases-conditions/allergies/symptoms-causes/syc- 20351497?p=1

3. WebMD. Allergy Medications. [online] [cited 2019 August 27] Available from: URL:
https://www.webmd.com/allergies/allergy-medications?print=true

4. Meltzer EO. Evaluation of the Optimal Oral Antihistamine for Patients With allergic Rhinitis. Mayo Clin Proc 2005;80(9):1170-1176.

5. ASCIA Society of Clinical Immunology and Allergy. Is it allergic rhinitis? [Online] [cited 2019 June18] Available from: URL:
https://www.allergy.org.au/patients/allergic-rhinitis-hay-fever-andsinusitis/ allergic-rhinitis-or-hay-fever

Managing Allergies – Management of urticaria (hives)

References:

1. American College of Allergy, Asthma & Immunology. Hives (Urticaria). [online] [cited 2019 August 28]. Available from: URL:
https://acaai.org/allergies/types-allergies/hives-urticaria

2. WebMD. Allergy Medications. [online] [cited 2019 August 28]. Available from: URL:
https://www.webmd.com/allergies/allergy-medications?print=true

3. Casale TB, Andrade C, Qu R. Safety and efficacy of Once Daily Fexofenadine HCI in the Treatment of Autumn Seasonal Allergic Rhinitis. Allergy and Asthma Proc 1999;20:193-198.

4. MayoClinic. Hives and angioedema. [online] [cited 2019 August 28]. Available from: URL:
https://www.mayoclinic.org/diseases-conditions/hives-and-angioedema/diagnosis-treatment/drc- 20354914?p=1

Prevention Tips – Tips to deal with allergens

References:

1. Asthma and Allergy Foundation of America, AAFA, Allergies. [online] [cited on 2019 August 28]. Available from: URL:
https://www.aafa.org/allergies.aspx.

2. MayoClinic. Dust mite allergy. Overview. [online] [cited on 2019 August 29]. Available from: URL:
https://www.mayoclinic.org/diseases-conditions/dust-mites/symptoms-causes/syc-20352173?p=1

3. MayoClinic. Dust mite allergy. Diagnosis. [online] [cited on 2019 August 28]. Available from: URL:
https://www.mayoclinic.org/diseases-conditions/dust-mites/diagnosis-treatment/drc-20352178?p=1

Prevention Tips – The impact of pollution on the prevalence of allergic diseases

References:

1. GivenGain. South African Allergy and clinical Immunology Foundation. [online] [cited on 16 Sep 2019] Available from: URL:
https://www.givengain.com/cause/9102/about

2. Pharma Dynamics. Effective and affordable healthcare. Allergies costing SA economy over half billion per year. [online] [cited on 16 Sep. 19] Available from: URL:
https://pharmadynamics.co.za/allergiescost-sa-over-half-a-billion-per-year/

3. Potter PC. Common indoor and outdoor aero-allergens in South Africa. Identification of the allergen that is responsible for symptoms is the key to the management of allergic patient. CME 2010:29(9):1- 4.

4. Pawankar R, Holgate ST, Canonica GW, Lockey RF, Blalss MS. World Allergy Organization (WAO). White Book on Allergy: Update 2013. 1-248.

5. Centre for Environmental Rights. Advancing Environmental Rights in South Africa. 2019 World Environment Day Highlights SA deaths from air pollution. [online] [cited on 16 Sep 2019] Available from: URL:
https://cer.org.za/news/2019-world-environment-day-highlights-sa-deaths-due-to-airpollution

6. World Economic Forum. 7 shocking facts about air pollution. [online] [cited on 16 Sep. 19] Available from: URL:
https://www.weforum.org/agenda/2016/10/air-pollution-the-true-cost-in-numbers/

7. Gonzàlez-Diaz A, Cruz A, Macouzet-Sànchez C, Partida-Ortega. Impact of air pollution in respiratory allergic diseases. Medicina Universitaria 2017;18(73):212-215.

8. Bartra J, Mullol J, de Cuvillo A, Dàvila I, Ferrer M, Jàuregui, Montoro J, Sastre J, Valero A. Air pollution and allergens. J Investig Allergol Clin Immunol 2007;17(Suppl 2):3-8.

TELFAST® – Claims references

Claim: NOTHING BEATS TELFAST FOR FAST, NON-DROWSY, 24 HOUR RELIEF*
References:

*Telfast® suspension is twice a day dosing

1. Finn Jr AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999 Nov;104(5):1071-8.

2. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.

3. Godse KV, Nadkarni NJ, Jani G, Ghate S. Fexofenadine in higher doses in chronic spontaneous urticaria. Indian Dermatol 2010;1(1):45.

4. Keam SJ, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders. Drugs 2007;67:457-74.

5. Metz M, Scholz E, Ferrán M, Izquierdo I, Giménez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010;104(1):86-92.

6. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84(5):517-22.

7. E.Paul, J.Berth-Jones, J-P.Ortonne. J Dermatol Treat. 1998;101:410–20.

8. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011;128(6):1139-1150.

9. Valero A, de la Torre F, Castillo JA, Rivas P, del Cuvillo A, Antépara I, et al. Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis: A Multicentre Open-Label Study in Spain. Drug Safety 2009;32:33-42.

S1 TELFAST® SUSPENSION. Each 1 ml contains 6 mg fexofenadine hydrochloride. Reg. No. 42/5.7.1/0339. For full prescribing information refer to professional information approved by the medicines regulatory authority.

S1 TELFAST® 120. Each tablet contains 120 mg fexofenadine hydrochloride per tablet. Reg. No.: 32/5.7.1/0446. For full prescribing information refer to professional information approved by the medicines regulatory authority.

S1 TELFAST® 180. Each tablet contains 180 mg fexofenadine hydrochloride per tablet. Reg. No.: 32/5.7.1/0447.

For full prescribing information refer to Professional Information approved by the medicines Regulatory Authority.
Applicant: Opella Healthcare South Africa (Pty) Ltd, Reg. no.: 2020/176440/07.
4th Floor, Building I, Hertford Office Park, 90 Bekker Road, Midrand, 1652.
www.sanofi.co.za